CBCT Guided Markerless SBRT for Renal Cell Cancer
Recruiting
N/A
Interventional Study
Renal Cell Carcinoma (RCC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with histologically proven non-metastastic RCC or high suspicion of RCC based on imaging without histological evidence
* No metastatic lesions
* Patients must be 18 years or older
* Ability to understand the requirements of the study and to give written informed conse…
Contacts
No contact information available.